Mark Cassanto & Associates

Some of the concerns about cell phone use have come from preliminary data from the 13-country study of cell phone use and tumors known as the Interphone study.  Release of the overall findings has been delayed for more than two years. But a group of European countries has reported "an elevated risk for certain brain tumors among long-term cell phone users, particularly on the side of the head where the phone was used."  (from Microwave News)

 

IF CANCER DOES NOT DEVELOP UNTIL 10 - 20 - 30 YEARS AFTER EXPOSURE, WE NEED TO RECOGNIZE THE MESSAGE THAT SCIENTISTS & GOVERNMENTS ALIKE ARE UNITED IN SAYING, THAT CHILDREN SHOULD BE SEEN AS THE FIRST BODY OF THE POPULATION THAT NEED TO BE LIMITED WITH THEIR EXPOSURE TO CELL PHONES.

 

"PRECAUTIONS ARE IMPORTANT... GLOBALLY IN AGREEMENT WITH RESTRICTING USE OF MOBILES AROUND CHILDREN."  Professor (Dr.) Elisabeth Cardis (Former Interphone Coordiantor) - a Canadian Scientist.

 

The director of the University of Pittsburgh Cancer Institute and UPMC Cancer Centers plans to issue an advisory to about 3,000 faculty and staff today about the possible health risks associated with cellular phone use. (Pittsburgh Post-Gazette)  ALSO - see similar news alerts from the media, including from Dr. Debra Davis, is the director of the Center for Environmental Oncology at the University of Pittsburgh Cancer Institute.

 

Based on this statement - see what other countries are saying.

The very rapid worldwide increase in mobile phone use in the last decade has generated considerable interest in the possible health effects of exposure to radio frequency (RF) fields. A multinational case–control study, INTERPHONE, was set-up to investigate whether mobile phone use increases the risk of cancer and, more specifically, whether the RF fields emitted by mobile phones are carcinogenic. The study focused on tumours arising in the tissues most exposed to RF fields from mobile phones: glioma, meningioma, acoustic neurinoma and parotid gland tumours. In addition to a detailed history of mobile phone use, information was collected on a number of known and potential risk factors for these tumours. The study was conducted in 13 countries. Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden, and the UK using a common core protocol. The paper describes the study design and methods and the main characteristics of the study population. INTERPHONE is the largest case–control study to date investigating risks related to mobile phone use and to other potential risk factors for the tumours of interest and includes 2,765 glioma, 2,425 meningioma, 1,121 acoustic neurinoma, 109 malignant parotid gland tumour cases and 7,658 controls. Particular attention was paid to estimating the amount and direction of potential recall and participation biases and their impact on the study results.